MapNeuro, Inc.

MapNeuro uses molecular methods to generate brain-wide maps of neuronal connectivity and gene expression at the cellular level. MapNeuro is now using these technologies to build a new in-vivo discovery platform for neurodegenerative and psychiatric disease.